tiprankstipranks
Trending News
More News >
Hikma Pharmaceuticals PLC (GB:HIK)
LSE:HIK
UK Market

Hikma Pharmaceuticals (HIK) Income Statement

Compare
58 Followers

Hikma Pharmaceuticals Income Statement

Last quarter (Q4 2024), Hikma Pharmaceuticals's total revenue was $1.56B, an increase of 19.48% from the same quarter last year. In Q4, Hikma Pharmaceuticals's net income was $133.00M. See Hikma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.13B$ 2.88B$ 2.52B$ 2.55B$ 2.34B
Gross Profit
$ 1.42B$ 1.41B$ 1.26B$ 1.30B$ 1.21B
Operating Expenses
$ 803.00M$ 1.04B$ 976.00M$ 715.00M$ 621.00M
Depreciation and Amortization
$ 179.00M$ 172.00M$ 193.00M$ 144.00M$ 91.00M
EBITDA
$ 787.00M$ 791.00M$ 485.00M$ 744.00M$ 654.00M
Operating Income
$ 612.00M$ 367.00M$ 591.00M$ 634.00M$ 540.00M
Other Income/Expenses
$ -157.00M$ -86.00M$ -49.00M$ -38.00M$ 18.00M
Pretax Income
$ 455.00M$ 281.00M$ 233.00M$ 544.00M$ 558.00M
Net Income
$ 359.00M$ 190.00M$ 188.00M$ 421.00M$ 431.00M
Per Share Metrics
Basic EPS
$ 1.61$ 0.85$ 0.84$ 1.82$ 1.83
Diluted EPS
$ 1.61$ 0.85$ 0.84$ 1.81$ 1.81
Weighted Average Shares Outstanding
222.98M 223.53M 223.73M 231.00M 236.00M
Weighted Average Shares Outstanding (Diluted)
223.49M 222.37M 225.00M 233.00M 238.00M
Currency in USD

Hikma Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis